All News

According to a recent study, the diabetes medication semaglutide is more effective as a 25 mg or 50 mg dose on its own, rather than a 14 mg add-on dose with other medications.

The drug, branded as Rezzayo, is the first FDA-approved invasive candidiasis treatment in over a decade.

The drug, called Leniolisib, is the first and only treatment approved in the United States for APDS, a rare primary immunodeficiency.

The risk of developing breast cancer was greater in women who are currently using or recently used progestogen-only contraceptives, a recent study showed.

The drug Leniolisib, now with the brand name Joenja, treats APDA, a genetic disorder that impairs the immune system. Its annual list price will be $547,500.

Vitamin D supplementation may be an effective and safe adjunctive prophylactic therapy to topiramate for children who experience migraine attacks, showed a study conducted in Saudi Arabia.

Speakers at the 2023 virtual Value-Based Insurance Design Summit discussed government programs and company initiatives to advance health equity, as well as the role of research and advocacy to achieve pharmacoequity.

Rural communities are often left without adequate assistance in times of need, but pharmacists can provide crucial care.

Investigators found a robust antigen-specific antibody response against HIV and Zika virus between mothers and newborns in a model using rabbits.

All children included in the analysis with presymptomatic SMA achieved swallowing, oral nutrition, and airway protection outcomes.

Regulatory officials said additional requirements are needed in order to approve the drug, which is under review for treatment of myelofibrosis, polycythemia vera, and graft-versus-host disease.

The proposed legislation, sponsored by Chuck Grassley and Maria Cantwell, aims to necessitate transparency from PBMs.

According to a study, patients are frequently prescribed broad-spectrum antibiotics instead of narrowly tailored antibiotics, which would be more optimized to treat them.

Dupilumab met both its primary and key secondary endpoints in a phase 3 trial, demonstrating efficacy as a potential treatment for atopic hand and foot dermatitis.

The drug, called Lumisight, is an optical imaging agent that detects cancerous tissue during initial lumpectomy to allow for a more complete resection. An NDA has been submitted to the FDA.

Evkeeza, which treats a rare form of high cholesterol, is now approved for patients as young of 5 years.

Here’s a look back at the cancer drugs that gained FDA approval in the winter of 2023.

Despite telehealth’s rise in popularity during the height of COVID-19, many individuals still aren't aware that it's a viable option.

Out of an abundance of caution, the infant formula giant has recalled one of their powdered infant formula products because of a potentially dangerous bacteria.

The company also will establish a $35 out-of-pocket price cap for for all patients with commercial insurance that use Latnus

There was a lower probability of initiating psycholeptics and experiencing postpartum psychiatric emergencies in study patients who continued using antidepressants

Your weekly roundup of the latest news from Drug Topics®.

Polio prevalence has been reduced by 99.99% in the past 35 years. But the disease continues to exist in countries like Pakistan and Afghanistan, where it seeds outbreaks elsewhere.

A combination of dabrafenib with trametinib was approved by the FDA for treatment of pediatric patients 1 year and older with low-grade glioma & BRAF V600E mutation who require systemic therapy.

The vaccine, developed by GSK, is "very encouraging" step in fight to treat meningococcal disease

Treating myelofibrosis with Jakafi earlier has shown promise in improving both survival and symptom burden

The combination of prednisone and methotrexate provided nearly complete or complete hair regrowth in up to 31.2% of patients with alopecia areata.